Drug Type Biological products |
Synonyms TE-8105 |
Target |
Mechanism GLP-1R antagonists(Glucagon-like peptide 1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 1 | AU | 07 Jun 2024 | |
Diabetes Mellitus, Type 2 | Phase 1 | AU | - | |
Nonalcoholic Steatohepatitis | Phase 1 | AU | - |